These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15922418)
1. Relationship between changes in prostate cancer cell proliferation, apoptotic index, and expression of apoptosis-related proteins by neoadjuvant hormonal therapy and duration of such treatment. Miyata Y; Kanda S; Sakai H; Hakariya T; Kanetake H Urology; 2005 Jun; 65(6):1238-43. PubMed ID: 15922418 [TBL] [Abstract][Full Text] [Related]
2. Expression of insulin-like growth factor binding protein-3 before and after neoadjuvant hormonal therapy in human prostate cancer tissues: correlation with histopathologic effects and biochemical recurrence. Miyata Y; Sakai H; Kanda S; Igawa T; Hayashi T; Kanetake H Urology; 2004 Jun; 63(6):1184-90. PubMed ID: 15183987 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis in prostate cancer: bax correlation with stage. Amirghofran Z; Monabati A; Gholijani N Int J Urol; 2005 Apr; 12(4):340-5. PubMed ID: 15948719 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix. Adhya AK; Srinivasan R; Patel FD Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067 [TBL] [Abstract][Full Text] [Related]
5. No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer. Noguchi M; Noda S; Nakashima O; Kojiro M Oncol Rep; 2002; 9(5):1075-80. PubMed ID: 12168076 [TBL] [Abstract][Full Text] [Related]
6. Absence of Bcl-2 expression favors response to the short-term administration of diethylstilbestrol diphosphate in prostate Cancer. Nagaoka A; Kubota Y; Kurosu S; Nakada T; Bilim V; Tomita Y; Motoyama T Prostate; 2006 Dec; 66(16):1779-87. PubMed ID: 16998806 [TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of heat shock protein 27 following neoadjuvant hormonal therapy is associated with poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer. Miyake H; Muramaki M; Kurahashi T; Yamanaka K; Hara I; Fujisawa M Anticancer Res; 2006; 26(2B):1583-7. PubMed ID: 16619575 [TBL] [Abstract][Full Text] [Related]
8. [Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis]. Li L; Yan L; Liu Z; Wang Z; Wen T; Chen X; Huang G Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):614-6, 120. PubMed ID: 11825479 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy. Paterson RF; Gleave ME; Jones EC; Zubovits JT; Goldenberg SL; Sullivan LD Mol Urol; 1999; 3(3):277-286. PubMed ID: 10851334 [TBL] [Abstract][Full Text] [Related]
10. Difficulties in interpreting specimens after neoadjuvant hormonal therapy and radiation with illustration of neuroendocrine differentiation. Civantos F Mol Urol; 2000; 4(3):117-21; discussion 123. PubMed ID: 11062365 [TBL] [Abstract][Full Text] [Related]
11. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma. Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075 [TBL] [Abstract][Full Text] [Related]
12. Expression of bcl-2, p53, and p21 in benign and malignant prostatic tissue before and after radiation therapy. Rakozy C; Grignon DJ; Sarkar FH; Sakr WA; Littrup P; Forman J Mod Pathol; 1998 Sep; 11(9):892-9. PubMed ID: 9758370 [TBL] [Abstract][Full Text] [Related]
13. Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life. Namiki S; Saito S; Tochigi T; Kuwahara M; Ioritani N; Yoshimura K; Terai A; Koinuma N; Arai Y Int J Urol; 2005 Feb; 12(2):173-81. PubMed ID: 15733112 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience. Debruyne FM; Witjes WP Mol Urol; 2000; 4(3):251-6;discussion 257. PubMed ID: 11062381 [TBL] [Abstract][Full Text] [Related]
15. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas. Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371 [TBL] [Abstract][Full Text] [Related]
16. Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy. Miyake H; Muramaki M; Kurahashi T; Yamanaka K; Hara I; Gleave M; Fujisawa M Urology; 2006 Sep; 68(3):609-14. PubMed ID: 16979705 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. Chen D; Zheng X; Kang D; Yan B; Liu X; Gao Y; Zhang K Med Princ Pract; 2012; 21(1):68-73. PubMed ID: 22024503 [TBL] [Abstract][Full Text] [Related]
18. Correlation between proliferation, apoptosis, and angiogenesis in prostate carcinoma and their relation to androgen ablation. Matsushima H; Goto T; Hosaka Y; Kitamura T; Kawabe K Cancer; 1999 Apr; 85(8):1822-7. PubMed ID: 10223578 [TBL] [Abstract][Full Text] [Related]
19. Significance of the Gleason scoring system after neoadjuvant hormonal therapy. Bentley G; Dey J; Sakr WA; Wood DP; Pontes JE; Grignon DJ Mol Urol; 2000; 4(3):125-;discussion 131. PubMed ID: 11062366 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation status of Fas-associated death domain-containing protein regulates telomerase activity and strongly correlates with prostate cancer outcomes. Matsumura Y; Shimada K; Tanaka N; Fujimoto K; Hirao Y; Konishi N Pathobiology; 2009; 76(6):293-302. PubMed ID: 19955841 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]